Epirubicin and ifosfamide in relapsed or refractory small cell lung cancer patients

Epirubicin and ifosfamide in relapsed or refractory small cell lung cancer patients:

... "ifosfamide 3g/m2 day 1–2 with uroprotection using mesna, and epirubicin 90mg/m2 day 1 given every four weeks until progression or unacceptable toxicity"

...High serum neuron-specific enolase (NSE) and brain metastases were the only independent negative prognostic variables...